The 2025 ASCO guidelines on sentinel lymph node biopsy (SLNB) for early-stage breast cancer are reshaping oncology care. Published in the Journal of Clinical Oncology, these recommendations, backed by extensive clinical trials, aim to reduce unnecessary procedures, lower costs, and address health disparities. Learn about the six key updates, their impact on patients, and how they promote personalized treatment while minimizing complications like lymphedema. Visit OncologyTube.com for more insights.
Browsing: ASCO Annual Meeting
Author: Dr. Shubham Pant, MD – MD Anderson Overview: At the ASCO 2024 conference, Dr. Shubham Pant, MD – MD…
Author: Dr. Zandra Klippel, Global Product Head, Multiple Myeloma, Sanofi At the ASCO 2024 conference, Dr. Zandra Klippel the Global…
Author: Dr. Alexis LeVee, City of Hope At the ASCO 2024 conference, Dr. Alexis LeVee from City of Hope presented…
Author: Dr. Regina Barragan-Carillo, City of Hope Overview: At ASCO 2024, Dr. Regina Barragan-Carillo from City of Hope Cancer Center…
Presented by Dr. Hedyeh Ebrahimi, City of Hope Overview: At the ASCO 2024 conference, Dr. Hedyeh Ebrahimi of City of…